BioFocus and InterMed Discovery agree marketing pact
Will provide advanced discovery of natural products
BioFocus and InterMed Discovery (IMD) have entered into a marketing collaboration to provide advanced discovery of natural products to the pharmaceutical, animal health, and agrochemical industries. No financial details were disclosed.
Under the terms of the collaboration, BioFocus, a supplier of drug discovery services located in Saffron Walden, UK, will use IMD’s natural product screening libraries and incorporate these as part of its own integrated drug discovery offerings.
‘We believe that the combination of our natural product capabilities with the well known discovery capabilities of BioFocus will offer a powerful discovery solution at a time when there is already growing demand from the pharma, veterinary and agro industries to fill depleted pipelines,’ said Thomas Henkel, co-managing director of InterMed Discovery.
BioFocus md Chris Newton, added: “We believe that when InterMed’s natural product libraries and services are combined with our screening services, our engine for drug discovery will be substantially enhanced and more cost-effective for our clients.”
Originally developed within Bayer Healthcare, the IMD natural product integrated discovery platform consists of natural compound libraries available to industry and a combination of data and research relating to natural compounds. With BioFocus’ screening technologies and integrated discovery capabilities, they amount to a strong platform in the discovery of biologically functional natural compounds.
